Antibody reactivity against <i>Helicobacter pylori</i> proteins in a sample of the Spanish adult population in 2008‐2013

  • Nerea Fernández‐de‐Larrea
    Environmental and Cancer Epidemiology Area National Center of Epidemiology Instituto de Salud Carlos III Madrid Spain
  • Angelika Michel
    Division of Molecular Diagnostics of Oncogenic Infections, Infection, Inflammation and Cancer Program German Cancer Research Center (DKFZ) Heidelberg Germany
  • Beatriz Romero
    Department of Microbiology Ramón y Cajal University Hospital (IRYCIS) Madrid Spain
  • Julia Butt
    Division of Molecular Diagnostics of Oncogenic Infections, Infection, Inflammation and Cancer Program German Cancer Research Center (DKFZ) Heidelberg Germany
  • Michael Pawlita
    Division of Molecular Diagnostics of Oncogenic Infections, Infection, Inflammation and Cancer Program German Cancer Research Center (DKFZ) Heidelberg Germany
  • Beatriz Pérez‐Gómez
    Environmental and Cancer Epidemiology Area National Center of Epidemiology Instituto de Salud Carlos III Madrid Spain
  • Gemma Castaño‐Vinyals
    Consortium for Biomedical Research in Epidemiology and Public Health (CIBER of Epidemiology and Public Health) Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP) Madrid Spain
  • Victor Moreno
    Consortium for Biomedical Research in Epidemiology and Public Health (CIBER of Epidemiology and Public Health) Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP) Madrid Spain
  • Vicente Martín
    Consortium for Biomedical Research in Epidemiology and Public Health (CIBER of Epidemiology and Public Health) Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP) Madrid Spain
  • Pilar Amiano
    Consortium for Biomedical Research in Epidemiology and Public Health (CIBER of Epidemiology and Public Health) Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP) Madrid Spain
  • Jesús Castilla
    Consortium for Biomedical Research in Epidemiology and Public Health (CIBER of Epidemiology and Public Health) Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP) Madrid Spain
  • Guillermo Fernández‐Tardón
    Consortium for Biomedical Research in Epidemiology and Public Health (CIBER of Epidemiology and Public Health) Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP) Madrid Spain
  • Trinidad Dierssen‐Sotos
    Consortium for Biomedical Research in Epidemiology and Public Health (CIBER of Epidemiology and Public Health) Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP) Madrid Spain
  • Juan Clofent
    Gastroenterology Department Sagunto University Hospital Sagunto Spain
  • Juan Alguacil
    Consortium for Biomedical Research in Epidemiology and Public Health (CIBER of Epidemiology and Public Health) Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP) Madrid Spain
  • José María Huerta
    Consortium for Biomedical Research in Epidemiology and Public Health (CIBER of Epidemiology and Public Health) Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP) Madrid Spain
  • José Juan Jiménez‐Moleón
    Consortium for Biomedical Research in Epidemiology and Public Health (CIBER of Epidemiology and Public Health) Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP) Madrid Spain
  • Aurelio Barricarte
    Consortium for Biomedical Research in Epidemiology and Public Health (CIBER of Epidemiology and Public Health) Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP) Madrid Spain
  • Amaia Molinuevo
    Consortium for Biomedical Research in Epidemiology and Public Health (CIBER of Epidemiology and Public Health) Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP) Madrid Spain
  • Tania Fernández‐Villa
    The Research Group in Gene Environment and Health Interactions (GIGAS) University of León León Spain
  • Delphine Casabonne
    Consortium for Biomedical Research in Epidemiology and Public Health (CIBER of Epidemiology and Public Health) Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP) Madrid Spain
  • Ángeles Sierra
    Environmental and Cancer Epidemiology Area National Center of Epidemiology Instituto de Salud Carlos III Madrid Spain
  • Manolis Kogevinas
    Consortium for Biomedical Research in Epidemiology and Public Health (CIBER of Epidemiology and Public Health) Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP) Madrid Spain
  • Silvia de Sanjosé
    Consortium for Biomedical Research in Epidemiology and Public Health (CIBER of Epidemiology and Public Health) Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP) Madrid Spain
  • Marina Pollán
    Environmental and Cancer Epidemiology Area National Center of Epidemiology Instituto de Salud Carlos III Madrid Spain
  • Rosa del Campo
    Department of Microbiology Ramón y Cajal University Hospital (IRYCIS) Madrid Spain
  • Tim Waterboer
    Division of Molecular Diagnostics of Oncogenic Infections, Infection, Inflammation and Cancer Program German Cancer Research Center (DKFZ) Heidelberg Germany
  • Nuria Aragonés
    Environmental and Cancer Epidemiology Area National Center of Epidemiology Instituto de Salud Carlos III Madrid Spain

抄録

<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Differences in <jats:italic>Helicobacter pylori</jats:italic> protein expression have been related to the risk of severe gastric diseases. In Spain, a marked geographic pattern in gastric cancer mortality has long been reported. Objective: To characterize antibody reactivity patterns against 16 <jats:italic>H. pylori</jats:italic> proteins, by age, sex, and region of birth, in a large sample of the Spanish adult population.</jats:p></jats:sec><jats:sec><jats:title>Materials and Methods</jats:title><jats:p>Antibody reactivity was quantified by <jats:italic>H. pylori</jats:italic> multiplex serology in a sample from the control group of the multicase‐control study <jats:styled-content style="fixed-case">MCC</jats:styled-content>‐Spain. For this analysis, 2555 population‐based controls were included. Each participant was classified as seropositive or seronegative for each protein according to specific cutoffs. Overall <jats:italic>H. pylori</jats:italic> seroprevalence was defined as positivity against ≥4 proteins. Descriptive analyses by age, sex, and region of birth were performed for both seroprevalence and seroreactivity (continuous measure). Differences among groups were tested by logistic and linear regression models.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Overall <jats:italic>H. pylori</jats:italic> seroprevalence increased with age in both sexes. For ages 55‐74, seroprevalence was lower in women than in men (84% vs 92%, <jats:italic>P</jats:italic><.001). Region of birth explained 7% of the variability in seroprevalence. Among <jats:italic>H. pylori</jats:italic> seropositive subjects, proteins with the highest seroprevalence were Gro<jats:styled-content style="fixed-case">EL</jats:styled-content>, NapA, <jats:styled-content style="fixed-case">HP</jats:styled-content>231, and Omp. Seropositivity for most of the proteins increased or remained stable with age, rising mainly for CagA, Gro<jats:styled-content style="fixed-case">EL</jats:styled-content>, and HyuA in women. A clear cohort effect was not observed.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>This is the first study to describe the antibody patterns against 16 <jats:italic>H. pylori</jats:italic> proteins in the Spanish population. We found variability in the <jats:italic>H. pylori</jats:italic> antibody profiles according to both individual factors such as age and sex, and environmental factors such as the region of birth. The slightness of the reduction in seropositivity with decreasing age highlights the ongoing importance of this infection.</jats:p></jats:sec>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ